প্রতিলিপি 🔗
WEBVTT
00:00:00.160 --> 00:00:03.040
Your patient has Hashimoto's hypothyroidism.
00:00:03.200 --> 00:00:06.160
She's been taking levithyroxine for six years.
00:00:06.320 --> 00:00:12.320
She takes her medication every morning, rarely misses a dose, and has her thyroid labs checked regularly.
00:00:12.480 --> 00:00:14.960
Her latest TSH is 1.6.
00:00:15.119 --> 00:00:17.440
Her free T4 is within range.
00:00:17.600 --> 00:00:20.960
According to her laboratory results, she's adequately treated.
00:00:21.120 --> 00:00:23.120
But she doesn't feel adequately treated.
00:00:23.280 --> 00:00:25.280
She's exhausted by the afternoon.
00:00:25.440 --> 00:00:27.920
Her concentration isn't what it used to be.
00:00:28.079 --> 00:00:33.759
She's having trouble managing her weight, and she tells you she hasn't felt like herself since her thyroid diagnosis.
00:00:33.920 --> 00:00:36.640
She's read about T4 to T3 conversion.
00:00:36.799 --> 00:00:43.920
She's heard that levithyroxine only replaces one thyroid hormone, and she's convinced that adding T3 is what she needs.
00:00:44.079 --> 00:00:45.119
So what do you do?
00:00:45.280 --> 00:00:59.840
Do you increase her levithyroxine, order a reverse T3, check her selenium and iodine levels, switch her to desiccated thyroid, or tell her that because her TSH is normal, her symptoms can't possibly be thyroid related?
00:01:00.000 --> 00:01:03.280
I don't think any of those should be our automatic response.
00:01:03.520 --> 00:01:08.959
Because this is where thyroid care becomes much more complicated than interpreting a TSH.
00:01:09.280 --> 00:01:15.840
And it's where understanding the physiology, the evidence, and the limitations of our treatments becomes essential.
00:01:16.079 --> 00:01:21.040
Today we're talking about what to do when a patient is receiving thyroid replacement therapy.
00:01:21.120 --> 00:01:25.439
The laboratory results look appropriate, but the patient still isn't well.
00:01:25.680 --> 00:01:30.799
Welcome to the Integrative Clinician, the podcast from Bridgewell Integrative Education.
00:01:31.040 --> 00:01:31.680
I'm Dr.
00:01:31.840 --> 00:01:36.319
Sheri Erwin, a nurse practitioner, educator, and founder of Bridgewell.
00:01:36.560 --> 00:01:48.400
In our last episode, we talked about what functional medicine gets right and wrong and why clinical reasoning needs to guide our decisions rather than protocols, supplements, or the latest laboratory trend.
00:01:48.640 --> 00:02:01.840
Today we're going to apply that thinking to one of the most debated areas of integrative medicine, thyroid treatment, and specifically the patient who continues to experience symptoms despite receiving thyroid hormone replacement.
00:02:02.079 --> 00:02:07.439
Now, this is not going to be another episode about whether a TSH of three or four is optimal.
00:02:07.680 --> 00:02:09.120
We've had those discussions.
00:02:09.280 --> 00:02:15.520
Instead, I want to get into what happens after the diagnosis has been established and treatment has already begun.
00:02:15.759 --> 00:02:20.560
Because sometimes the clinical challenge is not identifying hypothyroidism.
00:02:20.719 --> 00:02:25.280
It's figuring out what to do when treatment doesn't produce the improvement we expected.
00:02:25.439 --> 00:02:28.960
And that requires us to distinguish three different situations.
00:02:29.199 --> 00:02:44.400
A patient whose thyroid replacement is not actually adequate, a patient whose thyroid replacement is biochemically adequate, but who continues to have symptoms, and a patient who may never have had a clear indication for thyroid hormone in the first place.
00:02:44.560 --> 00:02:47.520
Those are three very different clinical problems.
00:02:47.759 --> 00:02:50.960
They should not automatically lead to the same treatment decision.
00:02:51.120 --> 00:02:53.039
Let's start with a hypothetical patient.
00:02:53.199 --> 00:02:54.400
We'll call her Melissa.
00:02:54.560 --> 00:02:56.080
Melissa is 52.
00:02:56.240 --> 00:03:01.919
Six years ago, she was diagnosed with primary hypothyroidism related to Hashimoto's thyroiditis.
00:03:02.080 --> 00:03:07.599
At the time of diagnosis, her TSH was elevated and her Free T4 was low.
00:03:07.759 --> 00:03:15.840
She was started on levithyroxine, and over several months her dose was adjusted until her TSH returned to the reference range.
00:03:16.080 --> 00:03:17.680
Initially, she felt better.
00:03:17.840 --> 00:03:19.439
Her constipation improved.
00:03:19.599 --> 00:03:21.039
She had more energy.
00:03:21.280 --> 00:03:23.360
She wasn't as cold all the time.
00:03:23.520 --> 00:03:26.639
But over the last year, some of her symptoms have returned.
00:03:26.800 --> 00:03:27.759
She's fatigued.
00:03:28.000 --> 00:03:29.680
Her concentration is poor.
00:03:29.840 --> 00:03:31.039
She's gaining weight.
00:03:31.199 --> 00:03:38.479
And she says that even though she's taking her thyroid medication faithfully, she feels like her thyroid is slowing down again.
00:03:38.719 --> 00:03:41.520
Her current TSH is 1.6.
00:03:41.840 --> 00:03:44.719
Her free T4 is within the laboratory range.
00:03:44.879 --> 00:03:48.479
She's taking 100 micrograms of levithyroxine daily.
00:03:48.560 --> 00:03:51.360
And she asks you a very reasonable question.
00:03:51.599 --> 00:03:55.199
If my thyroid numbers are normal, why do I still feel like this?
00:03:55.439 --> 00:03:57.439
Now I want you to consider something.
00:03:57.680 --> 00:04:01.759
There are two ways we can respond that I think are equally unhelpful.
00:04:02.000 --> 00:04:09.520
The first is to tell Melissa that her TSH is normal, so her thyroid treatment is fine, and there is nothing more to discuss.
00:04:09.680 --> 00:04:12.960
That dismisses the problem she came to us to address.
00:04:13.120 --> 00:04:16.480
But the second response can be just as problematic.
00:04:16.720 --> 00:04:22.079
We decide that her symptoms prove she isn't converting T4 to T3 properly.
Load full transcript
00:04:22.240 --> 00:04:26.240
And we prescribe T3 before considering any other possibilities.
00:04:26.480 --> 00:04:31.839
Now we've moved from dismissing the patient to assuming an explanation we haven't established.
00:04:32.079 --> 00:04:36.319
Neither approach reflects the kind of clinical reasoning I want us to practice.
00:04:36.480 --> 00:04:37.839
So where do we begin?
00:04:38.079 --> 00:04:45.519
We begin by verifying what we're treating, whether the treatment is being delivered effectively, and what the patient is actually experiencing.
00:04:45.759 --> 00:04:48.800
Here's something that gets overlooked surprisingly often.
00:04:49.040 --> 00:04:56.879
A patient can be prescribed an appropriate dose of levithyroxine and still have problems with how the medication is being taken or absorbed.
00:04:57.120 --> 00:05:01.680
Levithyroxine is a medication with a relatively narrow therapeutic index.
00:05:01.839 --> 00:05:12.560
Small changes in exposure can affect TSH, and its absorption can be influenced by other medications, supplements, food, and certain gastrointestinal conditions.
00:05:12.800 --> 00:05:21.759
So before I think about increasing Melissa's dose or adding another thyroid hormone, I want to understand exactly how she's taking what we've already prescribed.
00:05:22.000 --> 00:05:23.360
When does she take it?
00:05:23.600 --> 00:05:25.120
Does she take it with water?
00:05:25.360 --> 00:05:27.920
How long does she wait before eating breakfast?
00:05:28.160 --> 00:05:30.800
Does she drink coffee immediately afterward?
00:05:31.040 --> 00:05:34.720
Is she taking calcium or iron supplements at the same time?
00:05:34.959 --> 00:05:37.360
Has she started a proton pump inhibitor?
00:05:37.600 --> 00:05:40.560
Has she changed manufacturers or formulations?
00:05:40.720 --> 00:05:43.839
And has anything changed in her gastrointestinal health?
00:05:44.079 --> 00:05:45.600
Those details aren't trivial.
00:05:45.759 --> 00:05:49.120
Calcium and iron can interfere with levithyroxine absorption.
00:05:49.279 --> 00:05:54.879
Coffee and certain foods may also affect absorption depending on timing and formulation.
00:05:55.040 --> 00:05:59.600
Changes in gastric acidity and gastrointestinal disease can complicate the picture.
00:05:59.759 --> 00:06:10.319
So if a patient's TSH has become unexpectedly elevated despite an apparently adequate dose, the first answer isn't necessarily more thyroid medication.
00:06:10.560 --> 00:06:16.800
It might be correcting an administration problem or investigating a condition affecting absorption.
00:06:17.040 --> 00:06:23.279
For example, autoimmune thyroid disease can coexist with celiac disease or autoimmune gastritis.
00:06:23.439 --> 00:06:28.240
That doesn't mean every patient with Hashimoto's needs a large gastrointestinal workup.
00:06:28.399 --> 00:06:38.160
But if the clinical history suggests malabsorption or thyroid replacement requirements become unexpectedly high, those possibilities deserve consideration.
00:06:38.319 --> 00:06:41.360
Now, here's an important distinction in Melissa's case.
00:06:41.519 --> 00:06:45.519
Her TSH is 1.6 and it's been stable.
00:06:45.680 --> 00:06:54.319
That makes a major ongoing absorption problem less likely than it would be in someone whose TSH is consistently elevated or fluctuating substantially.
00:06:54.480 --> 00:07:01.600
So we should still review administration, but we shouldn't pretend we've found the explanation simply because she drinks coffee in the morning.
00:07:01.759 --> 00:07:04.399
Clinical findings have to fit the hypothesis.
00:07:04.639 --> 00:07:09.120
And that's exactly the kind of discipline that matters in integrative care.
00:07:09.360 --> 00:07:20.240
If a patient has an elevated TSH because she's routinely taking iron with her levithyroxy, correcting the timing may improve thyroid replacement without adding more medication.
00:07:20.720 --> 00:07:35.120
But if her TSH is stable and appropriate, we need to recognize that the persistent symptoms may have another explanation, or that thyroid replacement, even when biochemically adequate, doesn't always restore a patient's sense of well-being.
00:07:35.279 --> 00:07:37.839
Both possibilities deserve consideration.
00:07:38.319 --> 00:07:40.079
Let's talk about physiology.
00:07:40.319 --> 00:07:46.720
The thyroid gland normally produces predominantly T4 along with a smaller amount of T3.
00:07:47.040 --> 00:07:50.879
T4 functions largely as a circulating precursor.
00:07:51.040 --> 00:07:57.600
Through the activity of deodinase enzymes, T4 is converted to T3 in peripheral tissues.
00:07:57.920 --> 00:08:05.439
T3 interacts with nuclear thyroid hormone receptors and influences gene expression in numerous tissues.
00:08:05.680 --> 00:08:09.519
But this process is not identical in every tissue.
00:08:09.759 --> 00:08:14.560
Different deodinase enzymes help regulate local thyroid hormone availability.
00:08:14.720 --> 00:08:24.800
And the relationship between circulating hormone concentrations and tissue-level thyroid hormone effects is more complex than a simple blood test can fully represent.
00:08:25.040 --> 00:08:34.720
This is part of why researchers have continued to investigate whether levithyroxine monotherapy reproduces normal thyroid physiology in every patient.
00:08:34.960 --> 00:08:37.279
Now, I want to make an important distinction.
00:08:37.440 --> 00:08:46.000
Just because the physiology is complex does not prove that every patient with fatigue and a normal TSH has impaired thyroid hormone conversion.
00:08:46.159 --> 00:08:50.879
That's why we have to separate a plausible mechanism from an established clinical diagnosis.
00:08:51.120 --> 00:09:02.799
There are ongoing questions about differences in tissue level, thyroid hormone signaling, genetic variations in diodase pathways, and individual responses to replacement therapy.
00:09:02.960 --> 00:09:16.320
Those are legitimate areas of scientific
investigation, but we don't currently have a routinely validated clinical test that can identify every patient who would benefit from adding T3 based on a presumed conversion problem.
00:09:16.480 --> 00:09:18.960
And that includes reverse T3.
00:09:19.279 --> 00:09:23.679
Reverse T3 is produced through thyroid hormone metabolism.
00:09:23.919 --> 00:09:30.080
Its concentration can change during illness, altered energy balance, and other physiologic states.
00:09:30.240 --> 00:09:38.559
But measuring reverse T3 has not been shown to reliably identify patients who need T3 treatment for ordinary primary hypothyroidism.
00:09:38.720 --> 00:09:49.279
So if Melissa comes in with a reverse T3 result that somebody has labeled elevated, I don't automatically interpret that as evidence that she's unable to use thyroid hormone.
00:09:49.440 --> 00:09:54.159
I want to know what the measurement tells us and whether acting on it improves clinical outcomes.
00:09:54.399 --> 00:10:01.840
The existence of a physiologic pathway doesn't mean every measurement of that pathway is useful in clinical practice.
00:10:02.000 --> 00:10:06.000
And I think that distinction is especially important in functional medicine.
00:10:06.240 --> 00:10:10.080
We learn about these intricate relationships, which can be fascinating.
00:10:10.320 --> 00:10:15.120
Then we have to decide which of them are established well enough to guide treatment.
00:10:15.279 --> 00:10:21.759
Knowing more physiology should make us more careful about our conclusions, not more certain than the evidence allows.
00:10:22.000 --> 00:10:26.240
Now we're getting to one of the most controversial questions in thyroid management.
00:10:26.480 --> 00:10:31.679
Should we add T3 when patients remain symptomatic despite levithyroxine treatment?
00:10:31.919 --> 00:10:36.159
This debate has been going on for years, and it's important to understand why.
00:10:36.399 --> 00:10:41.200
Levithyroxine remains the standard first-line therapy for primary hypothyroidism.
00:10:41.360 --> 00:10:47.679
For most patients, it provides effective hormone replacement and produces substantial symptomatic improvement.
00:10:47.840 --> 00:10:54.320
But there is a subset of patients who continue to report impaired well-being despite biochemical normalization.
00:10:54.480 --> 00:10:56.480
And those patients deserve attention.
00:10:56.720 --> 00:11:02.080
The question is whether adding liothyrinine, which is synthetic T3, improves outcomes.
00:11:02.240 --> 00:11:09.600
Several randomized trials have compared levithyroxine alone with combinations of levithyroxine and liothyrinine.
00:11:09.759 --> 00:11:16.399
Taken together, those studies have not consistently demonstrated that combination therapy produces superior outcomes.
00:11:16.639 --> 00:11:22.720
There have been differences in study populations, treatment regimens, dosing ratios, and outcome measurements.
00:11:22.960 --> 00:11:26.480
Some patients express a preference for combination treatment.
00:11:26.639 --> 00:11:33.919
But patient preference, while important, is not the same as demonstrating consistent improvement in validated clinical outcomes.
00:11:34.240 --> 00:11:35.840
So where does that leave us?
00:11:36.159 --> 00:11:44.559
One of the more useful professional discussions came from the British Thyroid Association and Society for Endocrinology in their 2023 consensus statement.
00:11:44.799 --> 00:11:48.240
They acknowledged the clinical problem of persistent symptoms.
00:11:48.399 --> 00:11:58.799
They also acknowledged that the evidence for combination treatment remains uncertain, and they outlined a carefully selected group of patients in whom a monitored trial might be considered.
00:11:59.039 --> 00:12:04.639
The important point is that this is not a recommendation to add T3 whenever someone feels tired.
00:12:04.799 --> 00:12:15.919
The consensus emphasizes confirming the original diagnosis of overt hypothyroidism, ensuring adequate levithyroxine replacement, and assessing other potential causes of symptoms.
00:12:16.080 --> 00:12:19.919
It also recommends specialist involvement when considering a trial.
00:12:20.159 --> 00:12:31.440
Now, NICE Guidance takes a more conservative position and does not recommend routinely offering liothyrinine because evidence of benefit remains insufficient and long-term harms are uncertain.
00:12:31.679 --> 00:12:37.759
And in the United States, the American Thyroid Association has taken a broadly similar position.
00:12:38.000 --> 00:12:54.720
Its guidance does not endorse combination therapy as routine care, and it describes a trial of combination therapy as something to consider only in selected patients who remain symptomatic despite adequate levityroxine with appropriate monitoring.
00:12:54.960 --> 00:12:58.480
So on both sides of the Atlantic, the message is consistent.
00:12:58.639 --> 00:13:00.159
This is not a first move.
00:13:00.320 --> 00:13:07.200
It's a considered monitored option for a specific patient, not a reflex for anyone who feels tired on levithyroxine.
00:13:07.360 --> 00:13:10.720
I think nurse practitioners need to understand both perspectives.
00:13:10.960 --> 00:13:16.159
The fact that a treatment is controversial does not automatically mean it should never be discussed.
00:13:16.320 --> 00:13:20.799
But controversy is also not permission to bypass evidence or monitoring.
00:13:20.960 --> 00:13:35.200
And this becomes particularly important when we consider the potential risks of excessive thyroid hormone exposure, palpitations, tachyarrhythmias, atrial fibrillation, accelerated bone loss with chronic overtreatment.
00:13:35.360 --> 00:13:42.000
Those risks matter, particularly in patients with cardiovascular disease, osteoporosis risk, or advancing age.
00:13:42.159 --> 00:13:51.360
And they matter even when the patient reports feeling more energetic, because improved energy alone does not establish that a treatment is safe or
appropriate.
00:13:51.519 --> 00:13:56.559
We have to evaluate both the subjective response and the physiologic consequences.
00:13:56.720 --> 00:14:01.120
So for Melissa, I would not make the decision about T3 at the beginning of the visit.
00:14:01.279 --> 00:14:09.600
I would make sure we understand the original diagnosis, the adequacy and consistency of treatment, and the other potential contributors to her symptoms.
00:14:09.840 --> 00:14:21.919
Then, if there is still a compelling reason to consider combination therapy, that becomes a shared decision informed by the evidence, risks, monitoring requirements, and appropriate specialist collaboration.
00:14:22.080 --> 00:14:26.480
And it should have a clearly defined way to determine whether it has actually helped.
00:14:26.639 --> 00:14:31.840
Now I want to introduce another patient because I think this comparison is particularly useful.
00:14:32.000 --> 00:14:33.200
Let's call him David.
00:14:33.440 --> 00:14:34.720
David is 61.
00:14:34.799 --> 00:14:37.440
He has been taking levithyroxine for four years.
00:14:37.600 --> 00:14:43.519
His current dose is 175 micrograms daily, and his TSH is 9.2.
00:14:43.840 --> 00:14:49.840
He tells you that his provider has been increasing his dose almost every time his laboratory results are checked.
00:14:50.000 --> 00:14:54.240
He's tired, has constipation, and says the medication just doesn't seem to work.
00:14:54.480 --> 00:15:01.200
At first glance, you might think he needs another dose increase, but then you review how he's taking his medication.
00:15:01.440 --> 00:15:04.080
He takes his levithyroxine with breakfast.
00:15:04.240 --> 00:15:06.799
He takes an iron supplement at the same time.
00:15:06.960 --> 00:15:10.320
And he recently started a medication for acid reflux.
00:15:10.480 --> 00:15:12.879
Now we have a different clinical question.
00:15:13.120 --> 00:15:15.840
Unlike Melissa, David's T is elevated.
00:15:15.919 --> 00:15:21.279
We have biochemical evidence that his current treatment isn't producing the expected thyroid response.
00:15:21.519 --> 00:15:23.600
So now we need to determine why.
00:15:23.759 --> 00:15:25.919
Is the prescribed dose insufficient?
00:15:26.159 --> 00:15:28.559
Is he taking the medication inconsistently?
00:15:28.799 --> 00:15:31.840
Are medications or supplements interfering with absorption?
00:15:32.000 --> 00:15:36.720
Has he developed a gastrointestinal condition affecting bioavailability?
00:15:36.960 --> 00:15:40.399
Are there other factors increasing his hormone requirements?
00:15:40.639 --> 00:15:46.320
It's important not to assume that one of these explanations is correct before investigating.
00:15:46.559 --> 00:15:49.440
But you can see how the clinical decision changes.
00:15:49.600 --> 00:16:00.320
In David's case, we may need to address medication timing, review his other treatments, evaluate possible absorption problems, and repeat testing after appropriate adjustments.
00:16:00.480 --> 00:16:04.399
Simply adding T3 wouldn't necessarily solve the underlying problem.
00:16:04.639 --> 00:16:15.120
And continuing to increase levithyroxine without understanding the pattern could create problems if medication administration later changes and absorption improves.
00:16:15.360 --> 00:16:18.480
This is one of the reasons longitudinal monitoring matters.
00:16:18.639 --> 00:16:21.200
Medication requirements are not static.
00:16:21.440 --> 00:16:28.960
Changes in weight, medication exposure, gastrointestinal physiology, and other clinical factors can affect replacement needs.
00:16:29.200 --> 00:16:37.440
If you're treating thyroid disease, you need to understand the whole treatment environment, not just the prescribed dose and the most recent TSH.
00:16:37.759 --> 00:16:40.080
And here's the comparison I want you to remember.
00:16:40.399 --> 00:16:44.879
Melissa has persistent symptoms with biochemical evidence of adequate replacement.
00:16:45.039 --> 00:16:51.360
David has persistent symptoms with biochemical evidence that his thyroid replacement is not yet adequate.
00:16:51.519 --> 00:16:59.440
They may describe similar symptoms, but they do not have the same treatment problem, and they should not receive the same intervention.
00:16:59.679 --> 00:17:02.240
Now let's introduce a third situation.
00:17:07.039 --> 00:17:12.400
She started it two years ago after visiting a wellness clinic because she was fatigued and gaining weight.
00:17:12.559 --> 00:17:16.079
Her TSH before treatment was within the reference range.
00:17:16.240 --> 00:17:18.079
Her free T4 was normal.
00:17:18.240 --> 00:17:25.119
She had no documented history of thyroid surgery, radioactive iodine treatment, or established thyroid disease.
00:17:25.359 --> 00:17:31.920
She was told that her thyroid was sluggish because her free T3 was toward the lower end of the range.
00:17:32.079 --> 00:17:35.119
And she has been taking thyroid hormone ever since.
00:17:35.359 --> 00:17:38.720
Now she reports palpitations and difficulty sleeping.
00:17:38.960 --> 00:17:40.640
Her TSH is suppressed.
00:17:40.799 --> 00:17:41.519
What do we do?
00:17:41.759 --> 00:17:43.519
This is a different problem again.
00:17:43.759 --> 00:17:50.640
Before we discuss optimizing thyroid treatment, we need to ask whether there was an indication for treatment in the first place.
00:17:50.880 --> 00:17:57.359
A patient can experience fatigue, weight gain, and cognitive symptoms without having hypothyroidism.
00:17:57.519 --> 00:18:00.079
Those symptoms are important, but they are not specific.
00:18:00.240 --> 00:18:08.000
And prescribing thyroid hormone to treat them in a patient who is biochemically utterroid can expose the patient to unnecessary risk.
00:18:08.240 --> 00:18:12.480
This is where I think integrative medicine needs to be particularly disciplined.
00:18:12.640 --> 00:18:17.680
We cannot use thyroid hormone as a general treatment for fatigue or weight management.
00:18:17.839 -->
00:18:25.839
And we should not assume that a patient benefits from a particular medication simply because they report feeling better immediately after starting it.
00:18:26.000 --> 00:18:36.960
Subjective response matters, but it has to be weighed alongside the original indication, potential placebo effects, changes in other treatments, safety, and objective clinical data.
00:18:37.200 --> 00:18:44.079
In this patient's case, the suppressed TSH and palpitations raise concern for excessive thyroid hormone exposure.
00:18:44.240 --> 00:18:47.920
We need to assess the risks and manage the medication appropriately.
00:18:48.160 --> 00:18:56.319
That may involve reducing or discontinuing inappropriate thyroid treatment with suitable monitoring depending on the clinical history and circumstances.
00:18:56.559 --> 00:19:04.319
And if the original diagnosis is uncertain, we may need to carefully reassess whether genuine thyroid dysfunction exists.
00:19:04.559 --> 00:19:11.359
The lesson here is not that desiccated thyroid extract is automatically the same thing as inappropriate care.
00:19:11.599 --> 00:19:19.920
The larger issue is whether the patient needed thyroid hormone at all and whether the selected treatment has an acceptable risk-benefit profile.
00:19:20.160 --> 00:19:22.880
These decisions deserve careful review.
00:19:23.119 --> 00:19:27.599
Sometimes the most helpful thing we do for a patient is not add another medication.
00:19:27.680 --> 00:19:31.359
It's recognized that a previous treatment may not have been necessary.
00:19:31.599 --> 00:19:33.200
Let's return to Melissa.
00:19:33.359 --> 00:19:36.480
She has confirmed Hashimoto's hypothyroidism.
00:19:36.640 --> 00:19:39.200
And suppose she asks another question.
00:19:40.079 --> 00:19:42.160
My antibodies are still elevated.
00:19:42.319 --> 00:19:45.519
Does that mean my immune system is still attacking my thyroid?
00:19:45.680 --> 00:19:47.519
Shouldn't we be trying to lower them?
00:19:47.839 --> 00:19:51.680
This is a question that comes up frequently in integrative practice.
00:19:51.920 --> 00:19:55.279
Hashimoto's thyroiditis is an autoimmune disease.
00:19:55.519 --> 00:20:08.880
Thyroid peroxidase antibodies and thyroglobulin antibodies can support the diagnosis in the appropriate clinical context, and studying the immunologic processes involved in autoimmune thyroid disease is valuable.
00:20:09.200 --> 00:20:15.039
But we have to distinguish understanding the disease process from having a validated treatment target.
00:20:15.279 --> 00:20:24.880
Serially measuring thyroid antibodies to demonstrate that a supplement or dietary intervention is working is not generally part of recommended routine management.
00:20:25.039 --> 00:20:27.839
Antibody concentrations can change over time.
00:20:28.079 --> 00:20:37.200
And a reduction in an antibody level doesn't necessarily establish that the patient has improved clinically or that thyroid function has recovered.
00:20:37.359 --> 00:20:46.240
So if Melissa's TPO antibody concentration decreases after an intervention, I don't automatically conclude that we've reversed her Hashimoto's.
00:20:46.559 --> 00:20:50.079
I want to know whether there's a demonstrated benefit in an outcome that matters.
00:20:50.319 --> 00:20:52.400
Has her thyroid function changed?
00:20:52.640 --> 00:20:57.039
Has her medication requirement changed in a meaningful and sustained way?
00:20:57.359 --> 00:20:58.720
Have symptoms improved?
00:20:58.799 --> 00:21:02.400
And is the intervention safe and supported by adequate evidence?
00:21:02.640 --> 00:21:05.039
The same principle applies to selenium.
00:21:05.279 --> 00:21:12.240
Selenium has a legitimate role in thyroid hormone metabolism and antioxidant systems.
00:21:12.400 --> 00:21:19.279
Some studies of selenium supplementation and Hashimoto's have reported reductions in thyroid antibody concentrations.
00:21:19.519 --> 00:21:27.920
But the evidence has not consistently established meaningful clinical benefits for routine supplementation in all patients with Hashimoto's.
00:21:28.240 --> 00:21:35.039
A lower antibody result is not automatically equivalent to improved health, and excess selenium can be harmful.
00:21:35.200 --> 00:21:37.359
Iodine requires similar care.
00:21:37.599 --> 00:21:43.680
Iodine is essential for thyroid hormone synthesis, but more iodine is not necessarily better.
00:21:43.920 --> 00:21:51.279
Excess iodine can worsen thyroid dysfunction in susceptible individuals, including those with autoimmune thyroid disease.
00:21:51.519 --> 00:21:55.359
So before we recommend iodine, we need a clinical rationale.
00:21:55.519 --> 00:22:01.440
We need to consider dietary intake, true deficiency risk, and the Potential consequences.
00:22:01.680 --> 00:22:08.240
We should not recommend iodine simply because a patient has Hashimoto's and wants to support thyroid function.
00:22:08.400 --> 00:22:16.880
And we should not assume that a commercial micronutrient panel has established a need for replacement based on a narrow proprietary optimal range.
00:22:17.119 --> 00:22:21.440
This doesn't mean nutrition is irrelevant to autoimmune thyroid disease.
00:22:21.680 --> 00:22:22.960
Of course, it isn't.
00:22:23.200 --> 00:22:32.319
We should assess nutritional adequacy and recognize conditions that may coexist with Hashimoto's, such as celiac disease or autoimmune gastritis.
00:22:32.480 --> 00:22:40.160
We should address actual deficiencies when present, and we should support the patient's overall metabolic and cardiovascular health.
00:22:40.400 --> 00:22:46.559
But that is different from promising to reverse autoimmunity through a collection of supplements.
00:22:46.799 --> 00:22:50.799
Again, clinical reasoning should determine what belongs in the treatment plan.
00:22:50.960 --> 00:23:02.559
Now here's where I want to spend some time, because I don't want you to leave this episode thinking that the answer to persistent symptoms is
simply to tell patients their thyroid medication is fine and send them home.
00:23:02.799 --> 00:23:04.480
That isn't what I'm advocating.
00:23:04.720 --> 00:23:12.319
If Melissa still feels poorly, we need to continue investigating, but we need to do it in a way that reflects her clinical presentation.
00:23:12.559 --> 00:23:14.160
Let's revisit her history.
00:23:14.400 --> 00:23:15.440
She's 52.
00:23:15.599 --> 00:23:18.880
Her thyroid replacement has been stable for several years.
00:23:19.119 --> 00:23:24.240
She reports fatigue, concentration difficulties, weight changes, and disrupted sleep.
00:23:24.480 --> 00:23:26.319
Now we need to look at the timeline.
00:23:26.559 --> 00:23:29.440
Did the symptoms return after a medication change?
00:23:29.680 --> 00:23:31.680
Did they begin around menopause?
00:23:31.839 --> 00:23:33.759
Has she developed a sleep disorder?
00:23:34.000 --> 00:23:35.759
Has her physical activity changed?
00:23:35.920 --> 00:23:38.240
Are there medications contributing to fatigue?
00:23:38.400 --> 00:23:41.519
Is she experiencing depression or another health condition?
00:23:41.759 --> 00:23:47.119
Could she have anemia, an iron deficiency, B12 deficiency, or another problem?
00:23:47.359 --> 00:23:52.400
And are there symptoms or examination findings that point toward a more specific diagnosis?
00:23:52.640 --> 00:23:55.519
We don't automatically order every possible test.
00:23:55.839 --> 00:23:57.920
We use the history to prioritize.
00:23:58.160 --> 00:24:02.079
Suppose Melissa tells us her menstrual cycle stopped 18 months ago.
00:24:02.240 --> 00:24:06.079
She's having frequent night sweats, and she wakes several times each night.
00:24:06.319 --> 00:24:16.480
We now have a plausible explanation for at least part of her fatigue and concentration difficulty that may have little to do with the adequacy of her levithyroxine dose.
00:24:16.720 --> 00:24:20.400
Or suppose she reports loud snoring and daytime sleepiness.
00:24:20.559 --> 00:24:23.519
Now sleep apnea becomes an important consideration.
00:24:23.920 --> 00:24:30.160
Or suppose she has significant gastrointestinal symptoms and a history suggesting malabsorption.
00:24:30.319 --> 00:24:32.559
That changes our evaluation again.
00:24:32.799 --> 00:24:38.400
The goal is not to assume that every patient with persistent symptoms has a separate diagnosis.
00:24:38.559 --> 00:24:45.039
It's to remain open to other explanations when the thyroid results no longer adequately explain what we're seeing.
00:24:45.200 --> 00:24:46.799
And there's another important point.
00:24:47.039 --> 00:24:52.799
Patients can have established hypothyroidism and another unrelated condition at the same time.
00:24:53.039 --> 00:24:57.119
Finding one diagnosis does not protect them from developing another.
00:24:57.359 --> 00:25:02.880
Sometimes we become anchored to the thyroid because it was the first explanation that made sense.
00:25:03.119 --> 00:25:06.400
Then every new symptom gets attributed to that diagnosis.
00:25:06.640 --> 00:25:11.200
But clinical reasoning requires us to reassess our assumptions when the facts change.
00:25:11.359 --> 00:25:13.200
That's true in conventional medicine.
00:25:13.279 --> 00:25:17.119
And it's just as true in functional and integrative medicine.
00:25:17.279 --> 00:25:19.680
So let's bring the three patients back together.
00:25:19.920 --> 00:25:25.440
Melissa has confirmed overt hypothyroidism, stable treatment, and persistent symptoms.
00:25:25.599 --> 00:25:34.640
David has confirmed hypothyroidism with a TSH that remains elevated despite what appears to be a substantial levithyroxine dose.
00:25:34.799 --> 00:25:43.200
And our third patient is taking thyroid hormone without a clearly documented indication and now has symptoms suggesting over-treatment.
00:25:44.160 --> 00:25:45.359
Three patients.
00:25:45.599 --> 00:25:47.920
Three completely different clinical priorities.
00:25:48.079 --> 00:26:00.799
For Melissa, we need to confirm adequate treatment, assess other contributors to her symptoms, and consider whether additional thyroid-related evaluation or a specialist discussion about treatment options is justified.
00:26:00.960 --> 00:26:09.920
For David, we need to identify why his thyroid replacement isn't achieving the expected biochemical response before simply escalating or adding medication.
00:26:10.160 --> 00:26:18.079
And for the third patient, we need to address the safety of ongoing thyroid hormone treatment and reconsider whether treatment was indicated.
00:26:18.319 --> 00:26:22.640
This is what I want you to think about when you encounter a complex thyroid case.
00:26:22.799 --> 00:26:30.319
Not just what the laboratory values show, but what clinical decision those values support and what information is still missing.
00:26:30.559 --> 00:26:32.880
Sometimes a treatment adjustment is appropriate.
00:26:33.039 --> 00:26:35.440
Sometimes more investigation is necessary.
00:26:35.680 --> 00:26:39.359
Sometimes referral or co-management is the right choice.
00:26:39.599 --> 00:26:46.480
And sometimes the most important decision is to avoid an intervention that could create more risk than benefit.
00:26:46.720 --> 00:26:51.039
Now, I also want to acknowledge that patients may arrive with strong preferences.
00:26:51.279 --> 00:26:54.240
Some have read extensively about T3 therapy.
00:26:54.400 --> 00:26:57.839
Some have had a positive experience with desiccated thyroid.
00:26:58.000 --> 00:27:02.480
Others are concerned about synthetic medications and want a more natural approach.
00:27:02.799 --> 00:27:04.240
Those preferences matter.
00:27:04.400 --> 00:27:06.160
We should discuss them respectfully.
00:27:06.400 --> 00:27:13.519
But our responsibility is to help patients distinguish what is known, what remains uncertain, and what could be harmful.
00:27:13.680 --> 00:27:17.839
Shared decision making doesn't mean we agree to every requested treatment.
00:27:18.079 --> 00:27:25.519
It means patients have a meaningful role in decisions made with accurate information about benefits, risks, and alternatives.
00:27:25.680 --> 00:27:31.599
And that is particularly important in areas where evidence is evolving or professional guidance differs.
00:27:31.759 --> 00:27:40.400
You might be wondering why I consider this an integrative approach when we haven't spent much time discussing supplement protocols or specialty thyroid panels.
00:27:40.480 --> 00:27:42.160
And that's exactly the point.
00:27:42.400 --> 00:27:48.079
Integrative medicine should not be defined by the number of additional tests or treatments we introduce.
00:27:48.240 --> 00:28:00.640
For Melissa, an integrative approach means understanding thyroid physiology while also considering sleep, menopause, nutrition, mental health, medication exposure, and the broader clinical picture.
00:28:00.880 --> 00:28:08.640
It means understanding how different systems may interact without assuming that every interaction requires a new laboratory panel or treatment.
00:28:08.880 --> 00:28:14.880
It means recognizing the importance of nutrition without recommending iodine or selenium to everybody.
00:28:15.039 --> 00:28:21.440
It means being open to emerging research without treating a plausible mechanism as established clinical evidence.
00:28:21.599 --> 00:28:30.480
And it means knowing when conventional treatment is exactly the right treatment, if Melissa has well-controlled primary hypothyroidism on levithyroxine.
00:28:30.640 --> 00:28:34.559
We shouldn't change that simply because we're practicing integratively.
00:28:34.720 --> 00:28:39.920
We should change treatment when the clinical evidence and the patient's circumstances justify a change.
00:28:40.160 --> 00:28:44.559
That's the kind of decision making I want nurse practitioners to become confident in.
00:28:44.799 --> 00:28:50.000
Because as you learn more functional and integrative medicine, your treatment options expand.
00:28:50.079 --> 00:28:55.039
And with that expansion comes a greater responsibility to know when to use each option.
00:28:55.200 --> 00:29:00.720
More knowledge should lead to more thoughtful decisions, not automatically more interventions.
00:29:00.960 --> 00:29:03.920
So here's what I want you to remember from today's episode.
00:29:04.160 --> 00:29:14.720
When a patient is taking thyroid hormone and still doesn't feel well, the next step isn't automatically a higher dose, a T3 prescription, or another specialty laboratory panel?
00:29:14.960 --> 00:29:16.799
First, establish what you're treating.
00:29:17.039 --> 00:29:19.680
Was hypothyroidism clearly diagnosed?
00:29:19.839 --> 00:29:22.160
Is the patient receiving adequate replacement?
00:29:22.319 --> 00:29:25.519
Is the medication being taken and absorbed consistently?
00:29:25.759 --> 00:29:29.359
Do the laboratory findings support the diagnosis and treatment plan?
00:29:29.519 --> 00:29:36.000
And if the thyroid treatment appears adequate, what other clinical explanations deserve consideration?
00:29:36.240 --> 00:29:45.279
We also need to recognize that the evidence on combination thyroid hormone therapy is more complicated than either side of the debate sometimes acknowledges.
00:29:45.519 --> 00:29:48.079
There are patients who continue to have symptoms.
00:29:48.240 --> 00:29:52.480
There are important physiologic questions researchers are still trying to answer.
00:29:52.640 --> 00:29:59.119
And there are selected circumstances where specialist supervised alternative treatment strategies may be considered.
00:29:59.519 --> 00:30:06.079
But we have to balance those possibilities against the limitations of the evidence and the risks of overtreatment.
00:30:06.319 --> 00:30:12.160
This is why I believe advanced thyroid interpretation requires more than learning a laboratory panel.
00:30:12.319 --> 00:30:20.640
It requires understanding the physiology, the differential diagnosis, medication management, and the clinical reasoning behind treatment decisions.
00:30:20.799 --> 00:30:28.559
And that's exactly what we teach in our Advanced Thyroid Interpretation for Nurse Practitioners course at Bridgewell Integrative Education.
00:30:28.799 --> 00:30:37.839
We examine thyroid physiology, laboratory patterns, autoimmune disease, and treatment decisions, including situations where the answer is not straightforward.
00:30:38.000 --> 00:30:45.599
And we use clinical cases so you can see how the reasoning applies when you have a patient sitting in front of you who doesn't fit neatly into a protocol.
00:30:45.839 --> 00:30:51.920
If you want to strengthen your thyroid assessment and treatment decision making, you can explore the course at bridgewell.com.
00:30:52.079 --> 00:30:54.960
I'll also include a link in the episode notes.
00:30:55.119 --> 00:31:08.480
And if you're looking for broader education across the different areas of functional and integrative medicine, our Bridgewell Transformation Pathway brings those concepts together into a more comprehensive clinical learning experience.
00:31:08.799 --> 00:31:11.359
Before we close, I want to leave you with a question.
00:31:11.599 --> 00:31:19.279
The next time a patient tells you that their thyroid medication isn't working, don't immediately ask what else you can prescribe.
00:31:19.440 --> 00:31:26.799
Ask yourself, what evidence would convince me that this patient's symptoms are related to inadequate thyroid treatment?
00:31:26.960 --> 00:31:30.079
And what evidence would lead me to a different explanation?
00:31:30.319 --> 00:31:39.759
That question can change the direction of the entire encounter, because sometimes the thyroid is part of the story, and sometimes it's not the whole story.
00:31:40.000 --> 00:31:46.240
Next time on the Integrative Clinician, we're going to step back from any single organ system and look at testing itself.
00:31:46.480 --> 00:31:54.799
When another specialty panel actually earns its place, when it is just more information, and the three questions I ask before I order anything.
00:31:55.039 --> 00:31:59.839
The episode is called Are We Ordering the Right Tests or Just More Tests?
00:32:00.000 --> 00:32:00.559
I'm Dr.
00:32:00.640 --> 00:32:06.160
Sheri Erwin, and this has been the Integrative Clinician by Bridgewell Integrative Education.
00:32:06.319 --> 00:32:08.319
Thanks for listening, and I'll see you next time.